Year |
Citation |
Score |
2016 |
Szajek AY, Chess E, Johansen K, Gratzl G, Gray E, Keire D, Linhardt RJ, Liu J, Morris T, Mulloy B, Nasr M, Shriver Z, Torralba P, Viskov C, Williams R, ... ... Al-Hakim A, et al. The US regulatory and pharmacopeia response to the global heparin contamination crisis. Nature Biotechnology. 34: 625-630. PMID 27281424 DOI: 10.1038/Nbt.3606 |
0.481 |
|
2013 |
Ye H, Toby TK, Sommers CD, Ghasriani H, Trehy ML, Ye W, Kolinski RE, Buhse LF, Al-Hakim A, Keire DA. Characterization of currently marketed heparin products: key tests for LMWH quality assurance. Journal of Pharmaceutical and Biomedical Analysis. 85: 99-107. PMID 23917037 DOI: 10.1016/J.Jpba.2013.06.033 |
0.368 |
|
2013 |
Keire DA, Buhse LF, al-Hakim A. Characterization of currently marketed heparin products: composition analysis by 2D-NMR Analytical Methods. 5: 2984-2994. DOI: 10.1039/C3Ay40226F |
0.35 |
|
2012 |
Wang B, Buhse LF, Al-Hakim A, Boyne Ii MT, Keire DA. Characterization of currently marketed heparin products: analysis of heparin digests by RPIP-UHPLC-QTOF-MS. Journal of Pharmaceutical and Biomedical Analysis. 67: 42-50. PMID 22633605 DOI: 10.1016/J.Jpba.2012.04.033 |
0.363 |
|
2011 |
Sommers CD, Ye H, Kolinski RE, Nasr M, Buhse LF, Al-Hakim A, Keire DA. Characterization of currently marketed heparin products: analysis of molecular weight and heparinase-I digest patterns. Analytical and Bioanalytical Chemistry. 401: 2445-54. PMID 21901459 DOI: 10.1007/S00216-011-5362-Z |
0.329 |
|
2011 |
Zang Q, Keire DA, Buhse LF, Wood RD, Mital DP, Haque S, Srinivasan S, Moore CM, Nasr M, Al-Hakim A, Trehy ML, Welsh WJ. Identification of heparin samples that contain impurities or contaminants by chemometric pattern recognition analysis of proton NMR spectral data. Analytical and Bioanalytical Chemistry. 401: 939-55. PMID 21678118 DOI: 10.1007/S00216-011-5155-4 |
0.337 |
|
2011 |
Zang Q, Keire DA, Wood RD, Buhse LF, Moore CM, Nasr M, Al-Hakim A, Trehy ML, Welsh WJ. Combining (1)H NMR spectroscopy and chemometrics to identify heparin samples that may possess dermatan sulfate (DS) impurities or oversulfated chondroitin sulfate (OSCS) contaminants. Journal of Pharmaceutical and Biomedical Analysis. 54: 1020-9. PMID 21215547 DOI: 10.1016/J.Jpba.2010.12.008 |
0.378 |
|
2011 |
Zang Q, Keire DA, Wood RD, Buhse LF, Moore CM, Nasr M, Al-Hakim A, Trehy ML, Welsh WJ. Class modeling analysis of heparin 1H NMR spectral data using the soft independent modeling of class analogy and unequal class modeling techniques. Analytical Chemistry. 83: 1030-9. PMID 21192734 DOI: 10.1021/Ac102832T |
0.302 |
|
2011 |
Zang Q, Keire DA, Wood RD, Buhse LF, Moore CM, Nasr M, Al-Hakim A, Trehy ML, Welsh WJ. Determination of galactosamine impurities in heparin samples by multivariate regression analysis of their (1)H NMR spectra. Analytical and Bioanalytical Chemistry. 399: 635-49. PMID 20953772 DOI: 10.1007/S00216-010-4268-5 |
0.358 |
|
2011 |
Keire DA, Ye H, Trehy ML, Ye W, Kolinski RE, Westenberger BJ, Buhse LF, Nasr M, Al-Hakim A. Characterization of currently marketed heparin products: key tests for quality assurance. Analytical and Bioanalytical Chemistry. 399: 581-91. PMID 20680615 DOI: 10.1007/S00216-010-4023-Y |
0.346 |
|
2010 |
Brustkern AM, Buhse LF, Nasr M, Al-Hakim A, Keire DA. Characterization of currently marketed heparin products: reversed-phase ion-pairing liquid chromatography mass spectrometry of heparin digests. Analytical Chemistry. 82: 9865-70. PMID 21069966 DOI: 10.1021/Ac102301J |
0.307 |
|
2008 |
Guerrini M, Beccati D, Shriver Z, Naggi A, Viswanathan K, Bisio A, Capila I, Lansing JC, Guglieri S, Fraser B, Al-Hakim A, Gunay NS, Zhang Z, Robinson L, Buhse L, et al. Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events. Nature Biotechnology. 26: 669-75. PMID 18437154 DOI: 10.1038/Nbt1407 |
0.584 |
|
2008 |
Kishimoto TK, Viswanathan K, Ganguly T, Elankumaran S, Smith S, Pelzer K, Lansing JC, Sriranganathan N, Zhao G, Galcheva-Gargova Z, Al-Hakim A, Bailey GS, Fraser B, Roy S, Rogers-Cotrone T, et al. Contaminated heparin associated with adverse clinical events and activation of the contact system. The New England Journal of Medicine. 358: 2457-67. PMID 18434646 DOI: 10.1056/Nejmoa0803200 |
0.447 |
|
1994 |
Pervin A, al-Hakim A, Linhardt RJ. Separation of glycosaminoglycan-derived oligosaccharides by capillary electrophoresis using reverse polarity. Analytical Biochemistry. 221: 182-8. PMID 7985791 DOI: 10.1006/Abio.1994.1395 |
0.668 |
|
1992 |
Edens RE, al-Hakim A, Weiler JM, Rethwisch DG, Fareed J, Linhardt RJ. Gradient polyacrylamide gel electrophoresis for determination of molecular weights of heparin preparations and low-molecular-weight heparin derivatives. Journal of Pharmaceutical Sciences. 81: 823-7. PMID 1328601 DOI: 10.1002/Jps.2600810821 |
0.676 |
|
1991 |
Lee KB, al-Hakim A, Loganathan D, Linhardt RJ. A new method for sequencing linear oligosaccharides on gels using charged, fluorescent conjugates. Carbohydrate Research. 214: 155-68. PMID 1954629 DOI: 10.1016/S0008-6215(00)90538-X |
0.629 |
|
1991 |
Linhardt RJ, al-Hakim A, Liu JA, Hoppensteadt D, Mascellani G, Bianchini P, Fareed J. Structural features of dermatan sulfates and their relationship to anticoagulant and antithrombotic activities. Biochemical Pharmacology. 42: 1609-19. PMID 1930287 DOI: 10.1016/0006-2952(91)90431-4 |
0.529 |
|
1991 |
al-Hakim A, Linhardt RJ. Capillary electrophoresis for the analysis of chondroitin sulfate- and dermatan sulfate-derived disaccharides. Analytical Biochemistry. 195: 68-73. PMID 1909508 DOI: 10.1016/0003-2697(91)90296-6 |
0.516 |
|
1990 |
Linhardt RJ, Loganathan D, al-Hakim A, Wang HM, Walenga JM, Hoppensteadt D, Fareed J. Oligosaccharide mapping of low molecular weight heparins: structure and activity differences. Journal of Medicinal Chemistry. 33: 1639-45. PMID 2160537 DOI: 10.1021/Jm00168A017 |
0.652 |
|
1990 |
al-Hakim A, Linhardt RJ. Isolation and recovery of acidic oligosaccharides from polyacrylamide gels by semi-dry electrotransfer. Electrophoresis. 11: 23-8. PMID 1690641 DOI: 10.1002/Elps.1150110106 |
0.407 |
|
Show low-probability matches. |